Epidemiology, natural history and risk factors for anal intraepithelial neoplasia

Sexual Health

Volumn 9, Issue 6, 2012, Pages 547-555

  Coutĺe, Fraņois ^a,b,c   De Pokomandy, Alexandra ^c,d   Franco, Eduardo L ^c  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

HIV; human papillomavirus; intraepithelial lesions; men who have sex with men.

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS DNA;

ANUS CANCER; ANUS CARCINOMA; ARTICLE; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INCIDENCE; CANCER RISK; CD4 LYMPHOCYTE COUNT; CONDYLOMA ACUMINATUM; CROSS-SECTIONAL STUDY; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; MALE HOMOSEXUAL; PAPILLOMAVIRUS INFECTION; PREVALENCE; UTERINE CERVIX CARCINOMA IN SITU; VIRUS LOAD;

ADULT; ANAL CANAL; ANUS NEOPLASMS; CARCINOMA IN SITU; CAUSALITY; COMORBIDITY; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HIV SEROPOSITIVITY; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; MEDICAL HISTORY TAKING; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; UNITED STATES; VIRAL LOAD; WORLD HEALTH;

EID: 84870415893     PISSN: 14485028     EISSN: 14498987     Source Type: Journal    
DOI: 10.1071/SH11167     Document Type: Article

References (100)

1. Frisch M, Biggar IJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000; 92: 1500-10. doi:10.1093/jnci/92.18.1500
2. Palefsky JM, Holly EA, Ralston ML, Jay N, Berry JM, Darragh TM. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12: 495-503. doi:10.1097/00002030-199805000- 00011
3. Bower M, Powles T, Newsom Davis T, Thirlwell C, Stebbing J, Mandalia S, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004; 37: 1563-5. doi:10.1097/00126334-200412150-00004
4. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst 1998; 23: 15-20.
5. Palefsky JM. Anal squamous intraepithelial lesions: relation to HIV and human papillomavirus infection. J Acquir Immun Defic Syndr 1999; 21 (Suppl. 1): S42-8.
6. Powles T, Robinson D, Stebbing J, Sharmash J, Nelson M, Gazzard B, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009; 27: 884-90. doi:10.1200/JCO.2008.19.6626
7. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst 2009; 101: 1120-30. doi:10.1093/jnci/ djp205
8. Fang CT, Chang YY, Hsu HM, Twu SJ, Chen KT, Lin CC, et al. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiretroviral therapy. QJM 2007; 100: 97-105. doi:10.1093/qjmed/hcl141
9. Piketty C, Selinger Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008; 22: 1203-11. doi:10.1097/QAD.0b013e3283023f78
10. D'Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008; 48: 491-9. doi:10.1097/QAI.0b013e31817aebfe
11. Mathews WC. Screening for anal dysplasia associated with human papillomavirus. Top HIV Med 2003; 11: 45-9.
12. Palefsky JM. Cervical human papillomavirus infection and cervical intraepithelial neoplasia in women positive for human immunodeficiency virus in the era of highly active antiretroviral therapy. Curr Opin Oncol 2003; 15: 382-8. doi:10.1097/00001622- 200309000-00007
13. Zbar AP, Fenger C, Efron J, Beer-Gabel M, Wexner SD. The pathology and molecular biology of anal intraepithelial neoplasia: comparisons with cervical and vulvar intraepithelial carcinoma. Int J Colorectal Dis 2002; 17: 203-15. doi:10.1007/ s00384-001-0369-0
14. Fox PA. human papillomavirus and anal intraepithelial neoplasia. Curr Opinions Inf Dis 2006; 19: 62-6. doi:10.1097/01.qco. 0000199019.50451.a8
15. Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer 2011; 119: 5-19. doi:10.1002/cncy.20126
16. Goldstone SE, Winkler B, Ufford LJ, Alt E, Palefsky JM. High prevalence of anal squamous intraepithelial lesions and squamous cell carcinoma in men who have sex with men as seen in a surgical practice.DisColon Rectum2001; 44: 690-8. doi:10.1007/BF02234568
17. Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002; 35: 1127-34. doi:10.1086/344057
18. Frisch M, Glimelius B, van den Brule AJ, Wohlfahrt J, Meijer CJ, Walboomers JM, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-8. doi:10.1056/ NEJM199711063371904
19. Moscicki AB, Palefsky JM. Human papillomavirus in men: an update. J Low Genit Tract Dis 2011; 15: 231-4. doi:10.1097/ LGT.0b013e318203ae61
20. de Sanjosé S, Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Res 2002; 89: 201-11. doi:10.1016/ S0168-1702(02)00189-2
21. Kreuter A, Potthoff A, Brockmeyer NH, Gambichler T, Swoboda J, Stucker M, et al. Anal carcinoma in human immunodeficiency viruspositive men: results of a prospective study from Germany. Br J Dermatol 2010; 162:1269-77. doi:10.1111/j.1365-2133.2010.09712.x
22. Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg 2006; 76: 715-7. doi:10.1111/j.1445-2197.2006.03837.x
23. de Pokomandy A, Rouleau D, Ghattas G, Trottier H, Vezina S, Cote P, et al. Highly active antiretroviral therapy and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with Human Immunodeficiency Virus. Clin Infect Dis 2011; 52: 1174-81. doi:10.1093/cid/cir064
24. Chiao EY, Giordano TP, Palefsky JM, Tyring S, El-Serag H. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006; 43: 223-33. doi:10.1086/505219
25. Weis SE, Vecino I, Pogoda JM, Susa JS, Nevoit J, Radaford D, et al. Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum 2011; 54: 433-41. doi:10.1007/DCR.0b013e318207039a
26. Conley L, Bush T, Darragh TM, Palefsky JM, Unger ER, Patel P, et al. Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis 2010; 202: 1567-76. doi:10.1086/656775
27. Lacey HB, Wilson GE, Tilston P, Wilkins EG, Bailey AS, Corbitt G, et al. A study of anal intraepithelial neoplasia in HIV positive homosexual men. Sex Transm Infect 1999; 75: 172-7. doi:10.1136/sti.75.3.172
28. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281: 1822-9. doi:10.1001/jama.281.19.1822
29. Palefsky JM, Holly EA, Ralston ML, Arthur SP, Hogeboom CJ, Darragh TM. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med 1997; 73: 174-80.
30. Palefsky JM, Holly EA, Ralston ML, Arthur SP, Jay N, Berry JM, et al. Anal squamous intraepithelial lesions in HIV-positive and HIVnegative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr 1998; 17: 320-6. doi:10.1097/ 00042560-199804010-00005
31. Salit I, Tinmouth J, Chong S, Raboud J, Diong C, Su D. Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biomarkers Prev 2009; 18: 1986-92. doi:10.1158/1055-9965.EPI- 08-1141
32. Kiviat NB, Critchlow CW, Holmes KK, Kuypers J, Sayer J, Dunphy C, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS 1993; 7: 43-9. doi:10.1097/ 00002030-199301000-00007
33. Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopyguided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum 2009; 52: 239-47. doi:10.1007/DCR.0b013e31819793d9
34. Tilston P. Anal human papillomavirus and anal cancer. J Clin Pathol 1997; 50: 625-34. doi:10.1136/jcp.50.8.625
35. Nathan M, Singh N, Garrett N, Hickey N, Prevost T, Sheaff M. Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findings. AIDS 2010; 24: 373-9. doi:10.1097/QAD. 0b013e328333ab8e
36. Palefsky JM, Holly EA, Gonzales J, Lamborn K, Hollander H. Natural history of anal cytologic abnormalities and papillomavirus infection among homosexual men with group IV HIV disease. J Acquir Immune Defic Syndr 1992; 5: 1258-65. doi:10.1097/ 00126334-199212000-00009
37. Palefsky JM, Holly EA, Hogeboom CJ, Ralston ML, DaCosta MM, Botts R, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr 1998; 17: 314-9. doi:10.1097/00042560-199804010- 00004
38. Critchlow CW, Surawicz CM, Holmes KK, Kuypers J, Daling JR, Hawes SE, et al. Prospective study of high grade anal squamous intraepithelial neoplasia in a cohort of homosexual men: Influence of HIV infection, immunosuppression and human papillomavirus infection. AIDS 1995; 9: 1255-62. doi:10.1097/00002030- 199511000-00007
39. Abramowitz L, Benabderrahmane D, Ravaud P, Walker F, Rioux C, Jestin C, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS 2007; 21: 1457-65. doi:10.1097/QAD.0b013e3281c61201
40. Abramowitz L, Benabderrahmane D, Baron G, Walker F, Yeni P, Duval X. Systematic evaluation and description of anal pathology in HIV-infected patients during the HAART era. Dis Colon Rectum 2009; 52: 1130-6. doi:10.1007/DCR. 0b013e3181a65f5f
41. Sobhani I, Vuagnat A, Walker F, Vissuzaine C, Mirin B, Hervatin F, et al. Prevalence of high-grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology 2001; 120: 857-66. doi:10.1053/gast.2001.22446
42. Wang C, Wright TC, Denny L, Kuhn L. Rapid rise in detection of human papillomavirus (HPV) infection soon after incident HIV infection among South African women. J Infect Dis 2011; 203: 479-86. doi:10.1093/infdis/jiq083
43. Chin-Hong PV, Vittinghoff E, Cranston RD, Browne L, Buchbinder S, Colfax G, et al. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 2005; 97: 896-905. doi:10.1093/jnci/dji163
44. Park IU, Palefsky JM. Evaluation and Management of Anal Intraepithelial Neoplasia in HIV-Negative and HIV-Positive Men Who Have Sex with Men. Curr Infect Dis Rep 2010; 12: 126-33. doi:10.1007/s11908-010-0090-7
45. Chin Hong PV, Berry JM, Cheng SC, Catania JA, Da Costa M, Darragh TM, et al. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 2008; 149: 300-6.
46. Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003; 138: 453-9.
47. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Ning L, et al. Acquisition of anal human papillomavirus (HPV) infection in women: the Hawaii HPV Cohort study. J Infect Dis 2008; 197: 957-66. doi:10.1086/529207
48. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, et al. Sequential acquisition of human papillomavirus (HPV) infection of the anus and cervix: the Hawaii HPV Cohort Study. J Infect Dis 2010; 201: 1331-9. doi:10.1086/651620
49. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr 2009; 52: 611-22. doi:10.1097/ QAI.0b013e3181b327ca
50. Hessol NA, Holly EA, Efird JT, Minkoff H, Schowalter K, Darragh TM, et al. Anal intraepithelial neoplasia in a multisite study of HIVinfected and high-risk HIV-uninfected women. AIDS 2009; 23: 59-70. doi:10.1097/QAD. 0b013e32831cc101
51. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001; 93: 843-9. doi:10.1093/jnci/93.11.843
52. Kojic EM, Cu Uvin S, Conley L, Bush T, Onyekwuluje J, Swan DC, et al. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/ AIDS in the era of effective therapy (the SUN study). Sex Transm Dis 2011; 38: 253-9.
53. Palefsky JM, Holly EA, Ralston ML, DaCosta MM, Greenblatt RM. Prevalence and risk factors for anal human papillomavirus infection in Human immunodeficiency (HIV)-positive and high risk HIVnegative women. J Infect Dis 2001; 183: 383-91. doi:10.1086/ 318071
54. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994; 83: 205-11.
55. Tandon R, Baranoski AS, Huang F, las Morenas A, Vragovic O, Sullivan M, et al. Abnormal anal cytology in HIV-infected women. Am J Obstet Gynecol 2010; 203: 21.e1-21.e6. doi:10.1016/j. ajog.2010.01.010
56. Gonçalves MA, Randi G, Arslan A, Villa LL, Burattini MN, Franceschi S, et al. HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infect Agent Cancer 2008. 3(5). doi:10.1186/1750-9378-3-5
57. Hillemanns P, Ellerbrock TV, Mcphillips S, Dole P, Alperstein S, Johnson D, et al. Prevalence of anal human papillomavirus infection and anal cytologic abnormalities in HIV-seropositive women. AIDS 1996; 10: 1641-7.
58. Melbye M, Smith E, Wohlfahrt J, Osterlind A, Orholm M, Bergmann OJ, et al. Anal and cervical abnormality in women - prediction by human papillomavirus tests. Int J Cancer 1996; 68: 559-64. doi:10.1002/(SICI)1097-0215(19961127)68: 5<559::AID-IJC1>3.0. CO;2-Y
59. Poizot-Martin I, Henry M, Benhaim S, Obry Roguet V, Figarella D, Tamalet C. High level of HPV 16 and 18 DNA load in anal swabs from male and female HIV-1 infected patients. J Clin Virol 2009; 44: 314-7. doi:10.1016/j.jcv.2009.02.003
60. Moscicki AB, Durako SJ, Houser J, Ma Y, Murphy DA, Darragh TM, et al. Human papillomavirus infection and abnormal cytology of the anus in HIV-infected and uninfected adolescents. AIDS 2003; 17: 311-20. doi:10.1097/00002030- 200302140-00004
61. Durante AJ, Williams AB, Da Costa M, Darragh TM, Khoshnood K, Palefsky JM. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev 2003; 12: 638-42.
62. Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer 2009; 124: 2375-83. doi:10.1002/ijc.24215
63. Gohy L, Gorska I, de Pokomandy A, Rouleau D, Ghattas G, Allaire G, et al. Genotyping of Human papillomavirus in anal biopsies and anal swabs collected from HIV-seropositive men with anal dysplasia. J Acquir Immun Defic Syndr 2008; 49: 32-9. doi:10.1097/ QAI.0b013e318183a905
64. Martin F, Bower M. Anal intraepithelial neoplasia in HIV positive people. Sex Transm Infect 2001; 77: 327-31. doi:10.1136/sti.77. 5.327
65. Palefsky JM, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIVpositive and HIV-seronegative homosexual men. J Acquir Immune Defic Syndr 1994; 7: 599-606.
66. Palefsky JL, Gonzales J, Greenblatt RM, Ahn DK, Hollander H. Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV disease. JAMA 1990; 263: 2911-6. doi:10.1001/jama.1990. 03440210061033
67. Friedman HB, Saah AJ, Sherman ME, Busseniers AE, Blackwelder WC, Kaslow RA, et al. Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men. J Infect Dis 1998; 178: 45-52.
68. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med 2000; 342: 792-800. [Review] [125 refs] doi:10.1056/ NEJM200003163421107
69. Frazer IH, Medley G, Crapper RM, Brown TC, Mackay IR. Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet 1986; 328: 657-60. doi:10.1016/S0140- 6736(86)90168-6
70. Law CL, Qassim M, Thompson CH, Rose BR, Grace J, Morris BJ, et al. Factors associated with clinical and sub-clinical anal human papillomavirus infection in homosexual men. Genitourin Med 1991; 67: 92-8.
71. Sonnex C, Scholefield JH, Kocjan G, Kelly G, Whatrup C, Mindel A, et al. Anal human papillomavirus infection: a comparative study of cytology, colposcopy and DNA hybridisation as methods of detection. Genitourin Med 1991; 67: 21-5.
72. Xi LF, Critchlow CW, Wheeler CM, Koutsky LA, Galloway DA, Kuypers J, et al. Risk of anal carcinoma in situ in relation to human papillomavirus type 16 variants. Cancer Res 1998; 58: 3839-44.
73. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177: 361-7. doi:10.1086/ 514194
74. de Pokomandy A, Rouleau D, Ghattas G, Vezina S, Cote P, Macleod J, et al. Prevalence, clearance and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis 2009; 199: 965-73. doi:10.1086/597207
75. Critchlow CW, Hawes SE, Kuypers JM, Goldbaum GM, Holmes KK, Surawicz CM, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 1998; 12: 1177-84. doi:10.1097/00002030- 199810000-00010
76. Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, et al. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis 2007; 196: 887-94. doi:10.1086/520883
77. Alvarez J, de Pokomandy A, Rouleau D, Ghattas G, Vezina S, Cote P, et al. Episomal and integrated Human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men. AIDS 2010; 24: 2355-63.
78. Da Costa MM, Hogeboom CJ, Holly EA, Palefsky JM. Increased risk of high-grade anal neoplasia associated with a human papillomavirus type 16 E6 sequence variant. J Infect Dis 2002; 185: 1229-37. doi:10.1086/340125
79. Wilkin TJ, Palmer S, Brudney KF, Chiasson MA, Wright TC. Anal intraepithelial neoplasia in heterosexual and homosexual HIVpositive men with access to antiretroviral therapy. J Infect Dis 2004; 190: 1685-91. doi:10.1086/424599
80. Palefsky JM, Holly EA, Efirdc JT, Da-Costa M, Jay N, Berry JM, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19: 1407-14. doi:10.1097/01.aids.00001810 12.62385.4a
81. Ciobotaru B, Leiman G, St John T, Hyman N, Ramundo M, Grace C. Prevalence and risk factors for anal cytologic abnormalities and human papillomavirus infection in a rural population of HIV-infected males. Dis Colon Rectum 2007; 50: 1011-6. doi:10.1007/s10350- 006-0873-y
82. Hogg RS, Yip B, Chan KJ, Wood E, Craib KJ, O'Shaughnessy MV, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286: 2568-77. doi:10.1001/jama.286. 20.2568
83. Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002; 360: 119-29. doi:10.1016/S0140-6736(02)09411-4
84. Palefsky J. Human papillomavirus infection in HIV-infected persons. Top HIV Med 2007; 15: 130-3.
85. Ogunbiyi OA, Scholefield JH, Raftery AT, Smith JH, Duffy S, Sharp F, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81: 365-7. doi:10.1002/bjs.1800810313
86. Koppe DC, Bandeira CB, Rosa MR, Cambruzzi E, Meurer L, Fagundes RB. Prevalence of anal intraepithelial neoplasia in women with genital neoplasia. Dis Colon Rectum 2011; 54: 442-5. doi:10.1007/DCR.0b013e3182061b34
87. Calore EE, Giaccio CM, Nadal SR. Prevalence of anal cytological abnormalities in women with positive cervical cytology. Diagn Cytopathol 2011; 39: 323-7. doi:10.1002/dc.21386
88. Ferenczy A, Franco EL. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002; 3: 11-6. doi:10.1016/ S1470-2045(01)00617-9
89. Fontaine J, Hankins C, Money D, Rachlis A, Pourreaux K, Ferenczy A, et al. Human papillomavirus type 16 (HPV-16) viral load and persistence of HPV-16 infection in women infected or at risk for HIV. J Clin Virol 2008; 43: 307-12. doi:10.1016/j.jcv.2008.07.013
90. Lima VD, Hogg RS, Harrigan PR, Moore D, Yip B, Wood E, et al. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy. AIDS 2007; 21: 685-92. doi:10.1097/QAD.0b013e32802ef30c
91. Cain LE, Cole SR, Chmiel JS, Margolick JB, Rinaldo CRJ, Detels R. Effect of highly active antiretroviral therapy on multiple AIDSdefining illnesses among male HIV seroconverters. Am J Epidemiol 2006; 163: 310-5. doi:10.1093/aje/ kwj045
92. Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008; 123: 187-94. doi:10.1002/ijc.23487
93. Clifford GM, Polesel J, Rickenbach M, Dal-Maso L, Keiser O, Kofler A, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 2005; 97: 425-32. doi:10.1093/jnci/ dji072
94. Partridge JM, Koutsky LA. Genital human papillomavirus infection in men. Lancet Infect Dis 2006; 6: 21-31. doi:10.1016/S1473-3099 (05)70323-6
95. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus infections and HPV-related diseases. Antivir Ther 2004; 9: 13-22.
96. Piketty C, Darragh TM, Heard I, Da Costa M, Bruneval P, Kazatchkine MD, et al. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004; 31: 96-9. doi:10.1097/01.OLQ.0000109515.75864.2B
97. Palefsky JM, Holly EA, Ralston ML, Da Costa M, Bonner H, Jay N, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 2001; 28: 422-8.
98. Aynaud O, Piron D, Barrasso R, Poveda JD. Comparison of clinical, histological, and virological symptoms of HPV in HIV-1 infected men and immunocompetent subjects. Sex Transm Infect 1998; 74: 32-4. doi:10.1136/sti.74. 1.32
99. Caliendo AM, St George K, Kao SY, Allega J, Tan BH, LaFontaine R, et al. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype AMPLICOR CMV MONITOR test in transplant recipients. J Clin Microbiol 2000; 38: 2122-7.
100. Lakatosh VP, Boroda AM, Lazarenko LM, Lianenko LO, Dubchak VI, Demchenko SI. The colposcopic characteristics of the pathological processes in the cervix uteri associated with papillomavirus infection. Lik Sprava 1999; 1: 67-70. [Ukrainian]